Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Large-Scale Investment of Baxter/Baxalta in Austria

The American pharmaceutical and biotechology giant Baxter is investing EUR 138 million in Krems, Austria under its new name of Baxalta. The production facility in Krems will be expanded and modernized, creating 100 new jobs.   

The American pharmaceutical group Baxter is divided as of now into new separate publicly listed companies, one for its medical products and the other for its bioscience operations. The biotech division will be called Baxalta effective immediately. The Austrian plants in Krems and Orth/Donau both fully belong to the new biotech company Baxalta.  

The project which was announced calls for a blood clotting drug to be produced in Krems starting in 2018. “Over the past years we have had good experience with our production plant in Krems. Not only do we find very well trained employees here, but above all the possibility to partner with IMC University of Applied Sciences Krems and other specific facilities provides many advantages. For this reason, last year we reached an agreement to cooperate with IMC on research projects”, says Michael Heinrich of Baxalta, justifying the decision.  

 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • ABA's Virtual Open Day

    28.05.2020 / 8.30 - 18.00, Online event

  • 18° Salone d’Impresa

    29. / 30.05.2020, Online

Austria Map

Find the perfect location for your company

Vienna’s unique location at the heart of Europe makes it an important centre and very popular with the global pharmaceutical and biotechnology industry. Vienna is where Eastern Europe meets Western Europe. Businesses located at this international hub benefit from well-established infrastructures and highly-qualified professionals. The significant growth in the Life Sciences sector in Vienna over the last few years is an indicator of the momentum in the industry.

ABF Pharmaceutical Services

ABF Pharmaceutical Services
More testimonials

news from the business location Austria

Less gold is sometimes better

Using an ultra-thin gold layer, scientists at the Vienna University of Technology succeeded in creating an almost optimal infrared absorber.

Support measures for companies affected by COVID-19

To stimulate the economy, either new programs may be established as a result of the draft law or existing support programs (e.g. aws, ÖHT) will be expanded. All measures introduced are intended to be applicable immediately and will be in force until the end of 2020. The measures currently introduced include the following areas:

More news All blog posts